STUDIO
BioInvent and CASI on their collaboration
In a BioStock Studio exclusive, Martin Welschof, CEO of BioInvent and Wei-Wu He, Chairman and CEO of the American biopharma company CASI Pharmaceuticals, joined...
RECOMMENDED READING
BioMarin’s gene therapy treatment receives EU approval
The European Medicines Agency (EMA) has approved BioMarin's gene therapy for the treatment of...
Lipum’s work with its Target Product Profile
Developing a so-called Target Product Profile is an important part of the drug development...
